LeapZipBlog: Johnson Paul's blog: Autoinjectors Market Is Expected To Reach Worth USD 2.7 Bn by 2022 | Credence Research

Autoinjectors Market Is Expected To Reach Worth USD 2.7 Bn by 2022 | Credence Research

July 10, 2019 by Johnson Paul  

According to the latest report published by Credence Research, Inc. “Global Autoinjectors Market By Device (Manual Injection Autoinjectors, Automated Injection Autoinjectors, Reusable Autoinjectors, Disposable Autoinjectors, Variable Dose Autoinjectors & Smart Autoinjectors), By Therapeutic Area (Anaphylaxis, Hormones, Anticoagulants, Emergency Medicine, Autoimmune Diseases, Infectious Diseases, Hematopoietics, Neurology, Reproductive Health) - Growth, Future Prospects and Competitive Assessment, 2016 - 2022,” the autoinjectors market was valued at USD 869.0 Mn in 2015, and is expected to reach USD 2,740.7 Mn by 2022, expanding at a CAGR of 18% from 2016 to 2022.

Browse the full report Global Autoinjectors Market - Growth, Opportunities, Competitive Analysis, and Forecast, 2016 – 2022 at https://www.credenceresearch.com/report/autoinjectors-market

Market Insights                                                  

The global autoinjectors market is anticipated to undergo swift progress during the forecast period. This market is characterized by rapid technological developments, growing count of severe allergy patients and growing awareness about self-administered prefilled injections. The demand for disposable autoinjectors will grow significantly during the forecast period.

Due to corresponding demands from drug administration industry, the biopharmaceutical companies worldwide have introduced several solutions for injectable drug delivery and are perpetually pushing for improvements in design and mechanism. It is expected that a significant part of new treatment introductions in the market will comprise of injectables, out of which autoinjectors is the fastest emerging drug delivery solutions, since these products deliver better patient experience and treatment adherence through safe self-administration at home. Apart from the offered patient benefits, reduction in the number of hospital visits can ultimately assist in reducing cost of healthcare and contain the burden on healthcare personnel. New ergonomic designs and mechanisms introduced in autoinjectors have also helped to efficiently address patient dexterity issues and minimize the risk of needle-stick injuries.

Autoinjectors are being increasingly considered by biopharmaceutical companies as an appropriate solution to commercialize their therapeutic solutions. However for successful commercialization and implementation of related strategies, the companies require detailed planning, thorough knowledge of drug-device combination mechanism, regulatory requirements and synergy with device manufacturers. Acting against this, biopharmaceutical companies and device manufacturers have varied product lifecycles and thus product development process may lead to gaps that might be crucial for the overall project and affect commercialization and profitability. It is hence crucial for biopharmaceutical companies to have in-depth understanding of every intermediate stage, the stage of entry of device manufacturer, meeting regulatory mandates and other such processes.

This market is intensely competitive, yet a handful of players take over significant market shares. Upcoming introductions of several autoinjector products in 2018 and future will bring significant movements in the overall autoinjectors market. Some of the key players operating in development, manufacture and sale of autoinjectors in the international markets are Biogen Idec, Inc., Becton, Dickinson and Company, Antares Pharma, Inc., Mylan, Inc., Novartis International AG, Unilife Corporation, Pfizer, Inc., Scandinavian Health Ltd., Ypsomed Holding AG, Sanofi S. A., Bayer AG, Emergent BioSolutions and others.

Download Free PDF Sample Request: https://www.credenceresearch.com/sample-request/58015

Table of Content

Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology

Chapter 2 Executive Summary
2.1 Autoinjectors Market, by Devices, 2015 (USD Mn)
2.2 Autoinjectors Market Share, by Therapeutic Area, 2015 (Value %)
2.3 Autoinjectors Market Share, by Geography, 2015 (Value %)

Chapter 3 Autoinjectors Market: Market Dynamics and Outlook
3.1 Introduction, Facts and Figures
3.2 Drivers
3.3 Challenges
3.4 Opportunities
3.5 Major Market Events Assessment
3.6 Attractive Investment Proposition
3.7 Competitive Analysis: Autoinjectors Market, by Key Market Players

Chapter 4 Global Autoinjectors Market Analysis, by Devices, 2013 - 2022 (USD Mn)
4.1 Preface
4.2 Manual Injection Autoinjectors
4.3 Automated Injection Autoinjectors
4.4 Reusable Autoinjectors
4.5 Disposable Autoinjectors
4.6 Variable Dose Autoinjectors
4.7 Smart Autoinjectors

Chapter 5 Global Autoinjectors Market Analysis, by Therapeutic Area, 2013 – 2022 (USD Mn)
5.1 Preface
5.2 Anaphylaxis
5.3 Anticoagulants
5.4 Autoimmune Diseases
5.5 Emergency Medicine
5.6 Infectious Diseases
5.7 Hematopoietics
5.8 Hormones
5.9 Neurology
5.10 Reproductive Health

Chapter 6 Global Autoinjectors Market Analysis, by Geography, 2013 – 2022 (USD Mn)
6.1 Preface
6.2 North America
6.2.1 United States
6.2.2 Canada
6.3 Europe
6.3.1 United Kingdom
6.3.2 Germany
6.3.3 Rest of Europe
6.4 Asia Pacific
6.4.1 Japan
6.4.2 China
6.4.3 Rest of Asia Pacific
6.5 Middle East and Africa (MEA)
6.6 Latin America

Do Inquiry before Buying for research report: https://www.credenceresearch.com/inquiry-before-buying/58015

Medium Blog: https://medium.com/@kumarganesh028/autoinjectors-market-is-expected-to-reach-worth-usd-2-7-bn-by-2022-credence-research-324cf235e222

About Us

Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared to this task.

Media Contact

Name: Chris Smith

Address: 105 N 1st ST #429,


Toll-Free (US/CANADA) Ph.: +1-800-361-8290

E-mail: sales@credenceresearch.com

Website: http://www.credenceresearch.com